Article Information
History
- January 28, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Kevin Guzman1,
- Rebecca Crowder1,
- Anna Leddy1,
- Noriah Maraba2,
- Lauren Jennings3,
- Shahriar Ahmed4,
- Sonia Sultana4,
- Baraka Onjare5,
- Lucas Shilugu5,
- Jason Alacapa5,
- Jens Levy5,
- Achilles Katamba6,
- Alex Kityamuwesi6,
- Aleksey Bogdanov7,
- Kateryna Gamazina7,
- Adithya Cattamanchi1,*,# and
- Amera Khan8,*,#
- 1University of California, San Francisco, United States of America
- 2The Aurum Institute, Johannesburg, South Africa
- 3Desmond Tutu Health Foundation, Cape Town, South Africa
- 4icddr,b, Dhaka, Bangladesh
- 5KNCV, The Hague, The Netherlands
- 6Makerere University, Kampala, Uganda
- 7PATH, Kiev, Ukraine
- 8Stop TB Partnership/TB REACH, Geneva, Switzerland
- ↵#Corresponding Authors: Amera, Khan, DrPH8
, amerak{at}stoptb.org, Global Health Campus, Chemin du Pommier 40, 1218 Geneva, Switzerland, Adithya Cattamanchi, MD1
, Adithya.Cattamanchi{at}ucsf.edu, 1001 Potrero Ave, San Francisco, CA, 94110 USA
Posted January 28, 2023.
Acceptability and feasibility of digital adherence technologies for tuberculosis treatment supervision: A meta-analysis of implementation feedback
